← Eichor
Study identifier: NCT04860141 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Preoperative Administration of Gabapentin in 3rd Molar Dental Extraction.

Condition: Dental Pain and Sensation Disorder · Pain, Postoperative  ·  Sponsor: Loma Linda University

PhasePhase 4
Planned participants98
Who can joinAll sexes, 18 Years to 59 Years
Healthy volunteersYes

About this study

This study is a double-blind, randomized, prospective, placebo-controlled single-center clinical research study in which 600 mg of gabapentin or placebo will be administered 2 hours preoperatively to 49 patients each undergoing wisdom teeth extraction. We will measure intraoperative opioid use, severity of pain, the number of analgesics taken, and side effect profiles (e.g. nausea/vomiting, dizziness) at the following intervals, 4 hour, 8 hour, 12 hour, 24, and 72 hour post-procedure.

This description comes directly from the study's public registry record.

Talk to the study team

Je Dong Ryu, DMD MD  ·  909-558-4423  ·  jryu@llu.edu

Sung Han, DDS MD  ·  909-558-4423  ·  shan@llu.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Loma Linda University HealthLoma Linda, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04860141